Tapinarof Effective for AD in Patients as Young as 2 years Tapinarof Effective for AD in Patients as Young as 2 years

Tapinarof cream, 1%, an aryl hydrocarbon receptor agonist, was approved in 2022 for treating plaque psoriasis in adults.MDedge News
Source: Medscape Pediatrics Headlines - Category: Pediatrics Tags: Dermatology News Source Type: news